1,2-Distearoyl-sn-glycero-3-phosphate sodium
Based on 1 Customer Validation
1,2-Distearoyl-sn-glycero-3-phosphate, sodium salt is a phospholipid commonly used as a component of liposome formulations and drug delivery systems. 1,2-Distearoyl-sn-glycero-3-phosphate, sodium salt has unique chemical properties that make it an effective tool for encapsulating drugs and delivering them to specific targets in the body. It acts as a stabilizer and emulsifier, which can improve the solubility and bioavailability of drugs.
For research use only. We do not sell to patients.
- Purity : 98.0%
- CAS No.: 108321-18-2
- Formula: C39H76NaO8P
- Molecular Weight:726.98
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
-
Help & FAQs
-
HY-N0322
Cholesterol (from animal)ERRα Agonist -
HY-125940
DPPGBiological Reagent -
HY-113437A
1,2-Dipalmitoyl-sn-glycerol 3-phosphate sodiumPhosphatidic Acid -
HY-111915
1,2-Dioleoyl-sn-glycero-3-phosphate sodium saltAnionic Lipid -
HY-W583868
1-Palmitoyl-2-oleoyl-sn-glycero-3-PEPhospholipid -
HY-130463
POPG sodiumPhospholipid -
HY-W040185
1,2-Dimyristoyl-sn-glycero-3-phosphate monosodiumPhospholipids -
HY-W322225
1,2-Dilauroyl-sn-glycero-3-phosphoethanolamineAnionic Phospholipid -
HY-141615
1,2-Dipalmitoyl-sn-glycero-3-phospho-N,N-dimethylethanolamineLiposome -
HY-W040193
DSPCLiposome Compound -
HY-112005
DOPEFerroptosis Inhibitor -
HY-B2235
LecithinEndogenous Metabolite
Biological Activity
Description
In Vitro
1,2-Distearoyl-sn-glycero-3-phosphate, sodium salt is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 108321-18-2
-
Appearance Solid
-
Molecular Weight 726.98
-
Formula C39H76NaO8P
-
Color White to off-white
-
SMILES
O=P(OC[C@H](OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O)(O[Na])O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
Methanol : 2 mg/mL (2.75 mM; ultrasonic and warming and heat to 60°C)
DMSO : < 1 mg/mL (insoluble or slightly soluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Protocol for Pharmacokinetic Study
Pharmacokinetic studies quantify how an organism handles a drug over time through absorption, distribution, metabolism, and excretion, and the core experimental readout is the concentration-time profile of parent drug and, when relevant, metabolites in biological matrices such as plasma, whole blood, urine, bile, or tissue. Pharmacokinetic analysis links dose, route, exposure, clearance, half-life, distribution, bioavailability, and systemic exposure to drug efficacy and toxicity hypotheses rather than measuring a signaling pathway directly. The literature links pharmacokinetics to drug-development phenotypes by showing that drug metabolism and pharmacokinetics influence compound progression, exposure-response interpretation, safety margins, dosing strategy, and failure risk during discovery and development. DMPK science contributes to compound optimization by integrating physicochemical properties, in vitro metabolism, transporter behavior, in vivo exposure, and pharmacodynamic contex
Purity & Documentation
-
Data Sheet (240 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| Methanol | 1 mM | 1.3756 mL | 6.8778 mL | 13.7555 mL | 34.3888 mL |
1,2-Distearoyl-sn-glycero-3-phosphate sodium Related Classifications
HY-115415 Related Classifications
Powered by Bioz